Alzheimer's Fast Track 2024
More than 60 scientists from all career stages gathered to discuss critical topics in the field of Alzheimer’s disease research at BrightFocus Foundation’s 16th annual Alzheimer’s Fast Track, held Oct. 2-4 in Chicago, IL.
About Alzheimer’s Fast Track
Learn from experts in the field of Alzheimer’s disease and related dementias at the Alzheimer’s Fast Track workshop. Designed for graduate students, postdoctoral fellows, and other early-career scientists focused on Alzheimer’s disease research, this immersive learning experience will accelerate your knowledge, expertise, and visibility in this exciting field.
2024 Event Details
October 2-4, 2024
Chicago, Illinois
Official pre-meeting to Society for Neuroscience
Contact researchgrants@brightfocus.org with questions.
What Attendees Are Saying
I cannot believe how much this BrightFocus Fast Track has shaped my knowledge, my career and me personally. I also made friends forever. Not only I am so much more prepared and more confident to write grants but also I gained skills to communicate and to share my science. This workshop is the greatest idea to help students build their careers more successfully. Every scientist should go through a workshop like this one. Thank you for the opportunity!
Amira Latif-Hernandez, PhD, Alzheimer’s Disease Research Grant Recipient and Fast Track Attendee
The BrightFocus team shows genuine care for their fellows and their individual career paths, which was evident during the Fast Track event. The opportunity to easily connect with mentors and receive personalized advice truly stood out.
Julie Ottoy, PhD, Alzheimer’s Disease Research Grant Recipient and Fast Track Attendee
Co-Chairs
Frank LaFerla, PhD
University of California, Irvine
Cynthia Lemere, PhD
Brigham and Women’s Hospital, Harvard Medical School
Sharyn Rossi, PhD
BrightFocus Foundation
Harry Steinbusch, PhD
Maastricht University,
The Netherlands
Related News & Research Breakthroughs
Article
FDA Clears Two Alzheimer's Blood Tests to Support More Accurate, Earlier Diagnoses
Two blood tests—PrecivityAD2 (C2N Diagnostics) and Elecsys pTau217 (Roche and Lilly)—have been cleared for use in clinical laboratory settings. Learn more about how the tests work and what FDA clearance means for people with cognitive impairment.
Article
Building a Better Model of Alzheimer’s By Studying Brain Tissue in a Dish
Dr. Dominik Paquet's lab is growing human brain tissue in the lab to uncover what mouse models can’t show.
Article
Breaking News Dispatch: Diversifying the Alzheimer’s Disease Treatment Portfolio
Read the latest research news and findings from the latest international Alzheimer’s conference.
Article
Leqembi At-Home Injectable Now FDA Approved for Starting Alzheimer’s Treatment
The FDA has extended approval for the at-home formulation of Leqembi to include starter, in addition to maintenance, doses, making treatment more accessible.
Press Release
BrightFocus Foundation, Alzheimer's LA Fund New AI-Driven Alzheimer's Research
Early-stage pilot grants aim to accelerate innovation and collaboration in Southern California.
Press Release
BrightFocus Foundation Launches "Let's Talk Alzheimer's" Podcast Featuring Top Experts in Alzheimer's Research
New podcast features world-class scientists and doctors discussing late-breaking Alzheimer’s and dementia research in plain language for families and caregivers.